What do systematic reviews say?

Flumazenil vs placebo

Flumazenil showed no clear difference in all‐cause mortality compared with placebo (low certainty).

• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy 2017 · Cochrane Headline outcomes only
  RR 0.75 [0.48, 1.16]
  11 studies · 842 participants
  Low

Flumazenil vs placebo

Flumazenil may leads to lower hepatic encephalopathy compared with placebo (low certainty).

• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy 2017 · Cochrane Headline outcomes only
  RR 0.75 [0.71, 0.8]
  9 studies · 824 participants
  Low

Flumazenil vs placebo

• Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy 2017 · Cochrane Headline outcomes only
  no estimate extracted
  11 studies · 842 participants
  Low